Antipodean Advisors’s Humana HUM Stock Holding History

Antipodean Advisors’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-184,000	Closed	-$35.2M	–	34
2015 Q2	$35.2M	Buy	+184,000	New	+$34.1M	3.64%	10

Other funds holding HUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Antipodean Advisors's HUM Position: Q3 2015 in Review

Antipodean Advisors sold out of Humana (HUM) in Q3 2015, closing a stake of 184,000 shares — an estimated $35.2M sold.

Antipodean Advisors first reported a position in HUM in Q2 2015 and held it in 1 quarter. The position peaked at $35.2M in Q2 2015. 548 funds tracked by Wall St. Rank hold HUM as of Q3 2015.

Antipodean Advisors reported no remaining Humana position as of Q3 2015 after selling out during the quarter.
Antipodean Advisors sold 184,000 Humana shares in Q3 2015, an estimated $35.2M.
Antipodean Advisors first reported a position in Humana in Q2 2015 and held it in 1 quarter.
Antipodean Advisors's Humana position peaked at $35.2M in Q2 2015.
548 funds tracked by Wall St. Rank held Humana as of Q3 2015.

Based on Antipodean Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.